<DOC>
	<DOCNO>NCT01044667</DOCNO>
	<brief_summary>The primary objective study evaluate gastrointestinal ( GI ) symptoms health relate quality life lung transplant recipient convert Mycophenolate Mofetil ( MMF ) Myfortic part standard immunosuppressive therapy .</brief_summary>
	<brief_title>A Gastrointestinal Quality Life Study Lung Transplant Recipients Converted From Mycophenolate Mofetil Myfortic</brief_title>
	<detailed_description>Subjects administer MMF part immunosuppression regimen lung transplantation high incidence GI symptom related known side-effects drug . Previous study show GI symptom important predictor health relate quality life solid organ transplant ( 1 ) . GI complication common lung transplant ( 2 ) . We hypothesize lung transplant patient convert MMF Myfortic significant reduction severity GI complaint . We also hypothesize improvement severity GI complaint lead improve quality life subject . The study also include data evaluate effect GI complaint health relate quality life . Patients complete questionnaire visit . Calls patient lung transplant center GI complaint query documented case report form research nurse study visit . Similarly , hospital admission GI relate complaint cohort document . Symptom severity health relate quality life assess follow questionnaire previously validate population lung transplant ( 1 ) . These questionnaire select specifically capture impact GI complaint related health relate quality life . The questionnaire complete patient : i.Gastrointestinal Quality Life Index ( GIQLI ) • The GIQLI 36-item questionnaire assess impact GI distress daily life ii.SF-36 Health Survey • `` The SF-36 Health Survey questionnaire capture practical , reliable , valid information functional health well-being patient ' point view '' ( 4 ) iii.EQ-5D Health Questionnaire • `` The EQ-5D standardize instrument use measure health outcome . It [ EQ-5D ] provide simple descriptive profile single value health status '' ( 5 ) Patients complete three questionnaire 4 outpatient visit occur : - patient come outpatient clinic visit initial hospital discharge lung transplantation complaint GI distress ( DAY 1-Convert Myfortic ) ; - 60 DAYS ; - 90 DAYS ; - 180 Days</detailed_description>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Ability willingness provide write informed consent adhere study regimen Recipients 1870 year age Patients undergone either single double lung transplant discharge standard MMF ( generic MMF use ) therapy complain GI symptom , think related immunosuppressive regimen Patients GI complaint think due factor immunosuppressive regimen Patients receive steroid treatment acute rejection Women childbearing potential agree use least two acceptable form contraception prior start study drug , take study drug , 6 week stop study drug Women positive serum urine pregnancy test visit 1 and/or continue study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>